ATS Investor Call
Sanofi a eu le plaisir de convier ses investisseurs et analystes à notre ATS Investor Call le 22 mai, 2023.
(18h00 – 19h30 CEST / 12:00pm – 1:30pm EDT)
Avec
Dietmar Berger, MD, PhD
Global Head of R&D ad interim
Bill Sibold
Executive Vice President, Specialty Care
Naimish Patel, MD
Therapeutic Area Head, Immunology & Inflammation
Elizabeth Laws, PhD
Global Program Head, Dupixent
Klaus F. Rabe, MD, PhD, FERS
Professor of Medicine, LungenClinic Großhansdorf, Germany
Surya P. Bhatt, MD, MSPH
Associate Professor of Medicine, University of Alabama at Birmingham